- Recent News Articles -
- Oncolys BioPharma and Chugai Pharmaceuticals agree to Terminate Exclusive License Agreement on Oncolytic Viral Immunotherapy, OBP-301(Telomelysin)
- Dr. Reddy’s Labs receives US FDA approval for Generic Revlimid (Lenalidomide).
- Australian Regulatory Agency, TGA Unveil New Classification of Active Medical Devices Inclusion to Software Based Medical Devices for Industry Guidance.
- TYRVAYA (Varenicline Solution) Oyster Point’s Drug becomes First FDA-approved Nasal Spray to Treat Dry Eyes.
- MSN Labs and Dr. Reddy`s Labs launched Patented Anti-Diabetic Pill Jardiance (Empagliflozin), leads to a Potential Legal Battle
ChemRobotics TimesTM Newletter
Subscribe ChemRobotics TimessTM for Top Updates in the Agrochemical & Pharmaceutical Sectors!!!